Silvia Veneroni

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Neoplasms 61%
3. Thymidine 56%
4. Biomarkers 48%
5. Kinetics 35%
6. Estrogen Receptors 35%
7. Colorectal Neoplasms 29%
8. Recurrence 27%
9. Survival 25%
10. S Phase 24%
11. Hepcidins 22%
12. Breast 22%
13. Tamoxifen 21%
14. Cisplatin 21%
15. Drug Therapy 19%
16. Glutathione Transferase 19%
17. Mouth 19%
18. lonidamine 17%
19. Non-Hodgkin's Lymphoma 17%
20. Progesterone Receptors 17%
21. IDN 5109 15%
22. Ploidies 15%
23. Bromodeoxyuridine 15%
24. Lymph Nodes 15%
25. Cell Proliferation 15%
26. Proteins 15%
27. ST 1481 15%
28. Elderly 14%
29. Biopsy 14%
30. MicroRNAs 14%
31. DNA 13%
32. Doxorubicin 13%
33. Ovarian Neoplasms 13%
34. Heterografts 13%
35. Genes 13%
36. Non-Small Cell Lung Carcinoma 13%
37. Early Diagnosis 13%
38. ATP Binding Cassette Transporter, Subfamily B, Member 1 12%
39. Single Nucleotide Polymorphism 12%
40. Adjuvant Radiotherapy 12%
41. DNA Mismatch Repair 11%
42. Squamous Cell Carcinoma 11%
43. Apoferritins 11%
44. Mouth Neoplasms 11%
45. Environmental Biomarkers 10%
46. Penetrance 10%
47. Circulating Tumor DNA 10%
48. Male Breast Neoplasms 10%
49. Therapeutics 10%
50. Lobular Carcinoma 10%